Effects of sodium glucose cotransporter 2 inhibitors and pioglitazone on FIB-4 index in metabolic-associated fatty liver disease.
Hepatology research : the official journal of the Japan Society of Hepatology（2023）
摘要
Treatment with SGLT2i causes a larger improvement in FIB-4 index than PIO in patients with MAFLD over 96 weeks.
更多查看译文
关键词
Fibrosis-4 index,diabetes mellitus,fibrosis,metabolic dysfunction-associated fatty liver disease,sodium glucose cotransporter 2 inhibitor
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要